Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Cost of Revenue (2013 - 2026)

Amarin Corp Plc\Uk (AMRN) posted quarterly Cost of Revenue of $27.2 million for Q2 2026, up 21.64% year-over-year from $22.4 million in Q2 2025, and down 0.52% quarter-over-quarter from $27.4 million in Q1 2026.

Amarin Corp Plcuk (AMRN) Cost of Revenue (2013 - 2026) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Cost of Revenue for 14 consecutive years, with $27.2 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Cost of Revenue rose 21.64% year-over-year to $27.2 million; the TTM figure through Jun 2026 stood at $108.1 million (up 7.36% YoY), while the FY2025 annual figure was $92.8 million, down 16.23% from the prior year.
  • Cost of Revenue slipped to $27.2 million in Q2 2026 per AMRN's latest filing, from $27.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $35.8 million in Q2 2022 and bottomed at $16.9 million in Q1 2025.
  • Historically, Cost of Revenue has averaged $26.5 million across 5 years, with a median of $25.9 million in 2023.
  • Annual changes were most pronounced in 2023 — Cost of Revenue slumped 35.22% — and 2026, when it surged 62.04%.
  • Amarin Corp Plc\Uk's Cost of Revenue stood at $35.0 million in 2022, then slipped by 15.51% to $29.6 million in 2023, then advanced by 19.64% to $35.4 million in 2024, then declined by 26.41% to $26.0 million in 2025, then gained by 4.5% to $27.2 million in 2026.
  • Business Quant data shows AMRN's Cost of Revenue at $27.2 million in Q2 2026, $27.4 million in Q1 2026, and $26.0 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn 8.05 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn 4.29 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn 4.40 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn 3.71 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn 2.52 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn 2.81 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn 1.58 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn 4.09 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn 3.04 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn 27.22 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 27.22 Mn
Jun 30, 2026 27.22 Mn
Mar 31, 2026 27.36 Mn
Mar 31, 2026 27.36 Mn
Dec 31, 2025 26.05 Mn
Dec 31, 2025 26.05 Mn
Sep 30, 2025 27.46 Mn
Sep 30, 2025 27.46 Mn
Jun 30, 2025 22.38 Mn
Jun 30, 2025 22.38 Mn
Mar 31, 2025 16.89 Mn
Mar 31, 2025 16.89 Mn
Dec 31, 2024 35.40 Mn
Dec 31, 2024 35.40 Mn
Sep 30, 2024 26.02 Mn
Sep 30, 2024 26.02 Mn
Jun 30, 2024 24.72 Mn
Jun 30, 2024 24.72 Mn
Mar 31, 2024 24.62 Mn
Mar 31, 2024 24.62 Mn